<PAGE>
FORM 8-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 21, 1997
ROBERTS PHARMACEUTICAL CORPORATION
- --------------------------------------------------------------------------------
(exact name of registrant as specified in its charter)
New Jersey 1-1-432 22-2429994
--------------- ----------- --------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification
incorporation) Number)
Meridian Center II
4 Industrial Way West
Eatontown New Jersey 07724
- --------------------------------------------------------------------------------
(Address of principal executive offices, including zip code)
Registrant's telephone number, including area code: 908-389-1182
Meridian Center II
4 Industrial Way West
Eatontown, New Jersey 07724
- --------------------------------------------------------------------------------
(Former name or former address, if changed from last report)
<PAGE>
-2-
Item 5. Other Events
------------
Roberts Pharmaceutical Corporation announced today that Mr. Joseph
N. Noonburg and the Honorable Marilyn Lloyd have joined its Board of
Directors.
Mr. Noonburg, a self employed consultant, has a 38 year background in
the pharmaceutical industry. Mr. Noonburg is former Senior Vice President of
Sales for the pharmaceutical firm of Reed & Carnick and General manager of
Strafford Miller, Reed & Carnick's generic drug division. Mr. Noonburg has
been actively involved in several pharmaceutical industry associations
including, the Pharmaceutical Research and Manufacturers Association,
National Wholesale Druggist Association and the National Association of Chain
Drug Stores.
Ms. Lloyd, a former Congresswoman, is a consultant for Lockheed Martin
Corporation and the Spectrum Group and serves on a number of boards including
the board of Lockheed Martin Energy Research Corporation. From 1974 through
1995, Ms. Lloyd represented Tennessee's Third Congressional District in the
U.S. House of Representatives. In addition to being Chairman of the Energy
Subcommittee of the House Science and Technology Committee, she championed
many initiatives promoting health care awareness for women and chaired the
Housing and Consumer Committee of the Committee on Aging. In addition to her
corporate board positions, Ms. Lloyd is a member of Secretary Pena's Energy
Advisory Board.
Mr. Noonburg and Ms. Lloyd now fill the two seats on the Board of
Directors previously held by Yamanouchi Group Holding, Roberts largest
shareholder. Under the terms of a stock purchase agreement, Yamanouchi is now
entitled to designate only one member of the board for election. Yamanouchi
has noted its continued interest in Roberts future and, while not designating
a nominee to Roberts Board at this time, retains the right to do so at a
future date.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ROBERTS PHARMACEUTICAL CORPORATION
----------------------------------
(Registrant)
Date: May 22, 1997 By: /s/ Anthony A. Rascio
----------------------------
Anthony A. Rascio
Vice President
